Harlan Robins steps down at Fred Hutch, focuses on role at Adaptive Biotechnologies
June 18, 2019 at 16:07 PM EDT
Adaptive Biotechnologies is preparing to go public with an initial stock price between $15 and $17 per share and will offer 12.5 million shares.
